Advertisement

CNS Drugs

, Volume 17, Issue 10, pp 763–769 | Cite as

Opinion and Evidence in Neurology and Psychiatry

From the World Literature
  • 16 Downloads

Reference

  1. Committee on Safety of Medicines. Safety of Seroxat (paroxetine) in children and adolescents under 18 years: contraindication in the treatment of depressive illness [online]. Available from URL: http://www.mhra.gov.uk [Accessed 2003 Jun 10]

References

  1. 1.
    Aisen PS, Schafer KA, Grundman M, et al. Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial. JAMA 2003 Jun 4; 289: 2819–26PubMedCrossRefGoogle Scholar
  2. 2.
    Launer LJ. Nonsteroidal anti-inflammatory drugs and Alzheimer disease: what’s next? JAMA 2003 Jun 4; 289: 2865–7Google Scholar

Reference

  1. Sellers EM, Tyndale RF, Fernandes LC. Decreasing smoking behaviour and risk through CYP2A6 inhibition. Drug Discov Today 2003 Jun; 8: 487–93PubMedCrossRefGoogle Scholar

Reference

  1. Duggan A, Warner J, Knapp M, et al. Modelling the impact of clozapine on suicide in patients with treatment-resistant schizophrenia in the UK. Br J Psychiatry 2003 Jun; 182: 505–8PubMedCrossRefGoogle Scholar

Reference

  1. Meador KJ, Loring DW, Hulihan JF, et al. Differential cognitive and behavioral effects of topiramate and valproate. Neurology 2003 May 13; 60: 1483–8PubMedCrossRefGoogle Scholar

Reference

  1. Wheeler Vega JA, Mortimer AM, Tyson PJ. Conventional anti-psychotic prescription in unipolar depression. I: an audit and recommendations for practice. J Clin Psychiatry 2003 May; 64: 568–74PubMedCrossRefGoogle Scholar

Reference

  1. Xu J, Culman J, Blume A, et al. Chronic treatment with a low dose of lithium protects the brain against ischemic injury by reducing apoptotic death. Stroke 2003 May; 34: 1287–92PubMedCrossRefGoogle Scholar

Reference

  1. Gill SS, Patel NK, Hotton GR, et al. Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nature Med 2003 May; 9: 589–95PubMedCrossRefGoogle Scholar

Reference

  1. Biederman J, Faraone SV, Monuteaux MC, et al. Growth deficits and attention-deficit/hyperactivity disorder revisited: impact of gender, development, and treatment. Pediatrics 2003 May; 111: 1010–6PubMedCrossRefGoogle Scholar

Reference

  1. Elliott RA, Payne K, Moore JK, et al. Clinical and economic choices in anaesthesia for day surgery: a prospective randomised controlled trial. Anaesthesia 2003 May; 58: 412–21PubMedCrossRefGoogle Scholar

Reference

  1. Taylor RE, Bailey CC, Robinson K, et al. Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: the International Society of Paediatric Oncology/United Kingdom Children’s Cancer Study Group PNET-3 Study. J Clin Oncol 2003 Apr 15; 21: 1581–91PubMedCrossRefGoogle Scholar

Reference

  1. Ziegler M, Castro-Caldas A, Del Signore S, et al. Efficacy of piribedil as early combination to levodopa in patients with stable Parkinson’s disease: a 6-month, randomized, placebo-controlled study. Mov Disord 2003 Apr; 18: 418–25PubMedCrossRefGoogle Scholar

Reference

  1. Ben-Menachem E, Axelsen M, Hellebo Johanson E, et al. Predictors of weight loss in adults with topiramate-treated epilepsy. Obes Res 2003 Apr; 11: 556–62PubMedCrossRefGoogle Scholar

Reference

  1. Kendall JM, Latter VS. Intranasal diamorphine as an alternative to intramuscular morphine: pharmacokinetic and pharmacodynamic aspects. Clin Pharmacokinet 2003; 42(6): 501–13PubMedCrossRefGoogle Scholar

Copyright information

© Adis Data Information BV 2003

Personalised recommendations